• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特应性皮炎患者对触发因素、遵循医学建议及疾病控制的看法:DATOP研究

Patient perspectives on triggers, adherence to medical recommendations, and disease control in atopic dermatitis: the DATOP study.

作者信息

Ortiz de Frutos F J, Torrelo A, de Lucas R, González M A, Alomar A, Vera Á, Ros S, Mora A M, Cuervo J

机构信息

Hospital Universitario 12 de Octubre, Madrid, España.

Hospital Infantil Universitario Niño Jesús, Madrid, España.

出版信息

Actas Dermosifiliogr. 2014 Jun;105(5):487-96. doi: 10.1016/j.ad.2014.01.004. Epub 2014 Mar 13.

DOI:10.1016/j.ad.2014.01.004
PMID:24630429
Abstract

INTRODUCTION AND OBJECTIVES

To analyze the triggers of atopic dermatitis (AD), adherence to medical recommendations, disease control, and health-related quality of life (HRQOL) from the patient's perspective.

PATIENTS AND METHODS

This was a multicenter, cross-sectional, epidemiological study with the participation of adults (age >16 years; n=125) and children (age, 2-15 years, n=116). Patients had a history of at least 12 months of moderate to severe AD with a moderate to severe flare (Investigator Global Assessment score>2) at the time of recruitment. The Mann-Whitney U test was used to evaluate relationships between disease severity, determined according to the Scoring in Atopic Dermatitis index, and triggers reported by patients, adherence to recommendations and pharmacological therapy, HRQOL, and patient-perceived control.

RESULTS

The most common triggers were cosmetic products, clothing, mites, detergents/soaps, and changes in temperature. In 47.2% of adults and 39.7% of children, pharmacological therapy was not initiated at flare onset. Adherence was highest to pharmacological therapy, skin moisturizing, and medical care recommendations. Disease control was considered insufficient by 41.6% of adults and 27. 6% of pediatric patients and, in adults, this was associated with the severity of AD (P=.014).

CONCLUSIONS

The therapeutic control of AD is susceptible to improvement, especially in adults. Although patients state that they follow medical recommendations, a significant percentage of patients do not apply recommended treatments correctly. Better education about the disease and its management would appear to be necessary to improve disease control and HRQOL.

摘要

引言与目的

从患者角度分析特应性皮炎(AD)的触发因素、对医疗建议的依从性、疾病控制情况以及健康相关生活质量(HRQOL)。

患者与方法

这是一项多中心、横断面的流行病学研究,有成人(年龄>16岁;n = 125)和儿童(年龄2 - 15岁,n = 116)参与。患者在招募时患有至少12个月的中度至重度AD且伴有中度至重度发作(研究者整体评估评分>2)。采用曼-惠特尼U检验来评估根据特应性皮炎指数评分确定的疾病严重程度与患者报告的触发因素、对建议和药物治疗的依从性、HRQOL以及患者感知的控制之间的关系。

结果

最常见的触发因素是化妆品、衣物、螨虫、洗涤剂/肥皂以及温度变化。在47.2%的成人和39.7%的儿童中,发作时未开始药物治疗。对药物治疗、皮肤保湿和医疗护理建议的依从性最高。41.6%的成人和27.6%的儿科患者认为疾病控制不足,在成人中,这与AD的严重程度相关(P = 0.014)。

结论

AD的治疗控制仍有改善空间,尤其是在成人中。尽管患者表示他们遵循医疗建议,但仍有相当比例的患者未正确应用推荐的治疗方法。为改善疾病控制和HRQOL,似乎有必要对该疾病及其管理进行更好的教育。

相似文献

1
Patient perspectives on triggers, adherence to medical recommendations, and disease control in atopic dermatitis: the DATOP study.特应性皮炎患者对触发因素、遵循医学建议及疾病控制的看法:DATOP研究
Actas Dermosifiliogr. 2014 Jun;105(5):487-96. doi: 10.1016/j.ad.2014.01.004. Epub 2014 Mar 13.
2
Health-related quality of life, patient satisfaction, and adherence to treatment in patients with moderate or severe atopic dermatitis on maintenance therapy: the CONDA-SAT study.中度或重度特应性皮炎维持治疗患者的健康相关生活质量、患者满意度及治疗依从性:CONDA-SAT研究
Actas Dermosifiliogr. 2013 Jun;104(5):409-17. doi: 10.1016/j.adengl.2013.04.004. Epub 2013 May 10.
3
Impact of atopic dermatitis on health-related quality of life in Spanish children and adults: the PSEDA study.特应性皮炎对西班牙儿童和成人健康相关生活质量的影响:PSEDA研究
Actas Dermosifiliogr. 2013 Jan;104(1):44-52. doi: 10.1016/j.ad.2012.03.008. Epub 2012 Jul 28.
4
[Assessment of an educational program in an "Atopic School": pilot study in 40 patients].["对一所'特应性学校'教育项目的评估:40例患者的试点研究"]
Ann Dermatol Venereol. 2002 Aug-Sep;129(8-9):1003-7.
5
Atopic dermatitis: impact on quality of life and patients' attitudes toward its management.特应性皮炎:对生活质量的影响及患者对其管理的态度。
Eur J Dermatol. 2012 Jan-Feb;22(1):97-105. doi: 10.1684/ejd.2011.1560.
6
Therapeutic patient education in children with moderate to severe atopic dermatitis: A multicenter randomized controlled trial in China.中度至重度特应性皮炎患儿的治疗性患者教育:一项中国的多中心随机对照试验。
Pediatr Dermatol. 2018 Jan;35(1):70-75. doi: 10.1111/pde.13362. Epub 2017 Dec 15.
7
A study of targeted enhanced patient care for pediatric atopic dermatitis (STEP PAD).一项针对儿童特应性皮炎的靶向强化患者护理研究(STEP PAD)。
Pediatr Dermatol. 2008 Jan-Feb;25(1):19-24. doi: 10.1111/j.1525-1470.2007.00575.x.
8
Climatotherapy at the Dead Sea: an effective treatment modality for atopic dermatitis with significant positive impact on quality of life.死海气候疗法:一种有效治疗特应性皮炎的方法,对生活质量有显著的积极影响。
Dermatitis. 2012 Mar-Apr;23(2):75-80. doi: 10.1097/DER.0b013e31824a6141.
9
An audit of the impact of a consultation with a paediatric dermatology team on quality of life in infants with atopic eczema and their families: further validation of the Infants' Dermatitis Quality of Life Index and Dermatitis Family Impact score.一项关于与儿科皮肤科团队会诊对特应性皮炎婴儿及其家庭生活质量影响的审计:婴儿性皮炎生活质量指数和皮炎家庭影响评分的进一步验证
Br J Dermatol. 2006 Dec;155(6):1249-55. doi: 10.1111/j.1365-2133.2006.07525.x.
10
Patient-centered, direct-access online care for management of atopic dermatitis: a randomized clinical trial.以患者为中心的、直接在线获取的特应性皮炎管理的医疗服务:一项随机临床试验。
JAMA Dermatol. 2015 Feb;151(2):154-60. doi: 10.1001/jamadermatol.2014.2299.

引用本文的文献

1
Defining "Flares" in Atopic Dermatitis: A Narrative Review.特应性皮炎中“发作”的定义:一项叙述性综述
Am J Clin Dermatol. 2025 Sep 1. doi: 10.1007/s40257-025-00966-4.
2
Impact on Major Life-changing Decisions in Patients with Atopic Dermatitis.特应性皮炎患者重大生活决策的影响。
Acta Derm Venereol. 2025 Apr 1;105:adv42241. doi: 10.2340/actadv.v105.42241.
3
Rocatinlimab Improves Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis: Results from a Double-Blind Placebo-Controlled Phase 2b Study.
罗卡替尼单抗改善中度至重度特应性皮炎成人患者的患者报告结局:一项双盲安慰剂对照2b期研究的结果
Dermatol Ther (Heidelb). 2024 Dec;14(12):3351-3366. doi: 10.1007/s13555-024-01303-z. Epub 2024 Nov 12.
4
Disease burden, clinical management and unmet treatment need of patients with moderate to severe atopic dermatitis; consensus statements, insights and practices from CERTADE (Central/Eastern EU, Russia, Turkiye AD Experts) Delphi panel.中度至重度特应性皮炎患者的疾病负担、临床管理及未满足的治疗需求;CERTADE(中东欧、俄罗斯、土耳其特应性皮炎专家)德尔菲小组的共识声明、见解与实践
Front Med (Lausanne). 2024 Jun 19;11:1402493. doi: 10.3389/fmed.2024.1402493. eCollection 2024.
5
Development of a Patient Journey Map for Improving Patient Experience and Quality of Atopic Dermatitis Care.绘制患者就医流程图以改善特应性皮炎护理的患者体验和质量
Dermatol Ther (Heidelb). 2024 Feb;14(2):505-519. doi: 10.1007/s13555-024-01100-8. Epub 2024 Feb 9.
6
Validation of a Questionnaire to Assess the Perception of Women with Atopic Dermatitis in Family Planning.评估特应性皮炎女性在计划生育中认知的问卷的验证。
Int J Environ Res Public Health. 2022 Aug 29;19(17):10753. doi: 10.3390/ijerph191710753.
7
Young adults' perceptions of living with atopic dermatitis in relation to the concept of self-management: a qualitative study.年轻成年人对特应性皮炎患者自我管理概念的认知:一项定性研究
BMJ Open. 2021 Jun 23;11(6):e044777. doi: 10.1136/bmjopen-2020-044777.
8
Advances and novel developments in environmental influences on the development of atopic diseases.环境因素对特应性疾病发展影响的进展与新进展
Allergy. 2020 Dec;75(12):3077-3086. doi: 10.1111/all.14624. Epub 2020 Oct 30.
9
Validation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitis.使用对接受生物制剂治疗的特应性皮炎患者的纵向调查验证特应性皮炎控制工具(ADCT©)
BMC Dermatol. 2019 Nov 6;19(1):15. doi: 10.1186/s12895-019-0095-3.
10
Biological Treatments in Atopic Dermatitis.特应性皮炎的生物治疗
J Clin Med. 2015 Apr 3;4(4):593-613. doi: 10.3390/jcm4040593.